Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects

被引：0

作者：

W C Stewart

D G Day

J A Stewart

K T Holmes

J N Jenkins

机构：

[1] Pharmaceutical Research Network,

[2] LLC,undefined

[3] Carolina Eye Institute at the University of South Carolina,undefined

[4] School of Medicine,undefined

[5] Atlanta Research Company,undefined

来源：

Eye | 2004年 / 18卷

关键词：

ocular tolerability; dorzolamide; brinzolamide;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Purpose To compare ocular tolerability of dorzolamide 2%, brinzolamide 1%, and placebo given three times daily.

引用

页码：905 / 910

页数：5

共 50 条

[1] Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects
Stewart, WC
Day, DG
Stewart, JA
Holmes, KT
Jenkins, JN
EYE, 2004, 18 (09) : 905 - 910
[2] Brinzolamide/TimololIn Open-Angle Glaucoma and Ocular Hypertension
Jamie D. Croxtall
Lesley J. Scott
Drugs & Aging, 2009, 26 : 437 - 446
[3] Brinzolamide/Timolol In Open-Angle Glaucoma and Ocular Hypertension
Croxtall, Jamie D.
Scott, Lesley J.
DRUGS & AGING, 2009, 26 (05) : 437 - 446
[4] Tolerability and efficacy of dorzolamide versus acetazolamide in patients with ocular hypertension or open-angle glaucoma
Stewart, WC
Halper, LK
Najarian, D
Johnson-pratt, L
Hartenbaum, D
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S664 - S664
[5] OCULAR HYPERTENSION OR EARLY GLAUCOMA - OCULAR HYPERTENSION VS OPEN-ANGLE GLAUCOMA
CHANDLER, PA
GRANT, WM
ARCHIVES OF OPHTHALMOLOGY, 1977, 95 (04) : 585 - 586
[6] Brinzolamide - A review of its use in the management of primary open-angle glaucoma and ocular hypertension
Cvetkovic, RS
Perry, CM
DRUGS & AGING, 2003, 20 (12) : 919 - 947
[7] Brinzolamide/timolol fixed combination for open-angle glaucoma and ocular hypertension
Hollo, Gabor
EXPERT REVIEW OF OPHTHALMOLOGY, 2009, 4 (02) : 129 - 133
[8] Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2000, 78 : 49 - 50
[9] Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle Glaucoma In Four European Countries
Jean-François Rouland
Claude Le Pen
Carlos Gouveia Pinto
Patrizia Berto
Gilles Berdeaux
PharmacoEconomics, 2003, 21 : 201 - 213
[10] The ocular comfort of TID-dosed brinzolamide 1.0% compared to TID-dosed dorzolamide 2.0% in patients with primary open-angle glaucoma or ocular hypertension
Stewart, R
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2603 - 2603

← 1 2 3 4 5 →